Provided by Tiger Trade Technology Pte. Ltd.

Addex Therapeutics Ltd

4.94
+0.37008.10%
Post-market: 4.61-0.3300-6.68%19:59 EDT
Volume:7.27M
Turnover:51.08M
Market Cap:6.25M
PE:-0.53
High:6.05
Open:5.87
Low:4.60
Close:4.57
52wk High:12.05
52wk Low:3.78
Shares:1.27M
Float Shares:1.08M
Volume Ratio:146.00
T/O Rate:672.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.2717
EPS(LYR):-9.4830
ROE:-122.28%
ROA:-23.59%
PB:1.52
PE(LYR):-0.52

Loading ...

NASDAQ Trade Halt Volatility Trading Pause at 02:50 Pm

Reuters
·
Aug 21

Addex Therapeutics announces publication of new ADX71743 preclinical research

TIPRANKS
·
Jul 08

Press Release: Addex Announces Publication of Research Highlighting Therapeutic Potential of Mglu7 Modulation in Regulating Sleep and Wakefulness

Dow Jones
·
Jul 08

Press Release: Addex Shareholders Approve All Resolutions at Annual General Meeting

Dow Jones
·
Jun 30

Addex Therapeutics Reports Q1 2026 Net Loss Of CHF 1.71M Versus CHF 1.47M A Year Ago, Cash CHF 0.9M

Benzinga Earnings
·
Jun 25

Press Release: Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Jun 25

Press Release: Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026

Dow Jones
·
Jun 22

Press Release: Addex Convenes Annual General Meeting 2026

Dow Jones
·
Jun 05

Addex Closes 2025 With CHF 6.7M Net Loss And CHF 1.6M Cash, Regains ADX71149 Rights And Invests In Stalicla

Benzinga Earnings
·
Apr 30

Press Release: Addex Reports Full Year 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Apr 30

Addex Therapeutics announces GABAB PAM candidate data

TIPRANKS
·
Apr 29

Press Release: Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model

Dow Jones
·
Apr 29

Addex Therapeutics says spin-out company to complete NTX-253 study in Q2

TIPRANKS
·
Apr 23

Press Release: Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026

Dow Jones
·
Apr 23

Press Release: Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model

Dow Jones
·
Apr 21

Addex Therapeutics Ltd – ADR trading resumes

TIPRANKS
·
Mar 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:56 AM

Reuters
·
Mar 18

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:58 AM

Reuters
·
Mar 11